The FAS expression was not related with the prognosis of renal carcinoma (OS, HR: 1.07 [0.84, 1.35], p=0.6, n=743 cases), hepatic cancer (OS, HR: 1.01 [0.78, 1.31], p=0.93, n=623 cases), head and neck carcinoma (OS, HR: 1.19 [0.87, 1.64], p=0.27, n=369 cases) and colorectal cancer (OS, HR: 1.25 [0.97, 1.61], p=0.08, n=741 cases) (Figure 1 and Table S1). The gene discussed is FAS; the disease is renal carcinoma.